• About
  • Keywords

Toxoplasma gondii & Human Phenotype

Compendium of Known Effects and Ongoing Research

exposure

Effects of cumulative herpesviridae and Toxoplasma gondii infections on cognitive function in healthy, bipolar, and schizophrenia subjects

January 3, 2017
Hamdani, N., Daban-Huard, C.,. Godin, O., Laouamri, H., Jamain, S., Attiba, D., Delavest, M., Lepine, J. P., Le Corvoisier, P., Houenou, J., Richard, J. R., Yolken, R. H., Krishnamoorthy, R., Tamouza, R., Leboyer, M., Dickerson, F. B.
Journal of Clinical Psychiatry 2017, 78: 18-27
Click for abstract
Objective: Schizophrenia and bipolar disorder are associated with cognitive impairment leading to social disruption. While previous studies have focused on the effect of individual infectious exposure, namely, Herpesviridae viruses or Toxoplasma gondii (T gondii), on cognitive functioning, the objective of the present study was to examine the effect of multiple infections on cognitive functioning in patients with schizophrenia and bipolar disorder and in healthy controls. Methods: Seropositivity to herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), cytomegalovirus (CMV), and T gondii was related to cognitive status among 423 participants (recruited between 2008 and 2014; 138 patients with bipolar disorder, 105 patients with schizophrenia [DSM-IV criteria], and 180 healthy controls) for episodic verbal memory (California Verbal Learning Test), working memory (Wechsler Adult Intelligence Scale, third edition), and premorbid intelligence quotient (National Adult Reading Test). Results: Seropositivity to and antibody levels of HSV-1 were significantly associated with working memory, which persisted after correction (backward digit span: beta = -0.10 [0.05], chi(2) = 33.89, P = .0001) in the overall sample. This association was particularly strong in the control group (beta = -0.18 [0.08], P = .04, Z = -3.55, P = .0008; corrected P = .012). Further, cumulative exposure to HSV-1, HSV-2, and CMV viruses and T gondii parasite was also associated with lower scores on working memory as measured by backward digit span in the overall sample (Z = 2.86, P = .004; Z = 2.47, P = .01; and Z = 3.35, P = .01, respectively). Conclusions: Exposures to Herpesviridae and T gondii parasite seem to impact cognitive functioning. Because infections caused by Herpesviridae and/or T gondii parasite are quite common in the (general) population, assessing and confirming the cognitive impairment among those who have cumulative exposures is useful and of interest.

Tagged: antibodies, cytomegalovirus, deficits, exposure, herpes-simplex-virus, impairment, lithium-carbonate, psychiatric-disorder, risk, type-1

Cognitive functionsMental health

Is Toxoplasma gondii infection a risk factor for leukemia? An evidence-based meta-analysis

October 6, 2016
Huang, Y., Chang, A. S., Wang, J. S., Zeng, X. Q.,
Medical Science Monitor 2016; 22.
Click for abstract
Background: Possible associations of parasite infection with cancer risk have recently attracted much attention. Published studies concerning the association between Toxoplasma gondii (T. gondii) infection and leukemia risk have generated inconsistent results. In the present study, we aimed to address this topic by conducting a quantitative meta-analysis. Material/Methods: Relevant publications were searched in electronic databases and eligible studies were rigorously screened and selected. Essential information was extracted and the data were pooled. Subgroup analysis on source of controls and detection target was also performed. Results: A total of 6 studies that met the inclusion criteria were selected. The overall data show that T. gondii infection might have an association with increased leukemia risk (OR=3.05; 95% CI=1.83-5.08). Similar results were shown in the subgroups regarding source of controls and detection target. Conclusions: Our results suggest that T. gondii infection might be a risk factor for leukemia, providing new insight into the etiology of leukemia. Future studies with large sample sizes in different geographic areas are needed to confirm this conclusion.

Tagged: association, b1 gene, cancer, children, cholangiocarcinoma, diagnosis, disease susceptibility, exposure, leukemia, meta-analysis, micrornas, prevalence, quality, Toxoplasma

Physical health

Maternal infection during pregnancy and risk of autism spectrum disorders: A systematic review and meta-analysis

January 4, 2016
Jiang, H. Y., Xu, L. L., Shao, L., Xia, R. M., Yu, Z. H., Ling, Z. X., Yang, F., Deng, M., Ruan, B.
Brain Behavior and Immunity 2016; 58: 165-172
Click for abstract
Conflicting evidence exists with regard to the relationship between maternal infection during pregnancy and the risk of autism spectrum disorder (ASD) in offspring. The aim of this meta-analysis was to systematically assess this relationship. To identify relevant studies, we conducted systematic searches in PubMed and Embase of scientific articles published through March 2016. Random-effects models were adopted to estimate overall relative risk. A total of 15 studies (2 cohort and 13 case-control studies) involving more than 40,000 ASD cases were included in our meta-analysis. Our results showed that maternal infection during pregnancy was associated with an increased risk of ASD in offspring (OR = 1.13, 95% confidence interval (CI): 1.03-1.23), particularly among those requiring hospitalization (OR = 1.30, 95% CI: 1.14-1.50). Subgroup analyses suggested that risk may be modulated by the type of infectious agent, time of infectious exposure, and site of infection. These findings indicate that maternal infection during pregnancy increases the risk of ASD in offspring. Possible mechanisms may include direct effects of pathogens and, more indirectly, the effects of inflammatory responses on the developing brain. (C) 2016 Elsevier Inc. All rights reserved.

Tagged: autism, brain-development, childhood, children, cytokines, Epidemiology, exposure, hospitalization, immune activation, infectious, prenatal, prenatal infection, prevalence, viral-infection

Mental health

Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels

October 6, 2015
Hamdani, N., Daban-Huard, C., Lajnef, M., Gadel, R., Le Corvoisier, P., Delavest, M., Carde, S., Lepine, J. P., Jamain, S., Houenou, J., Galeh, B., Richard, J. R., Aoki, M., Charron, D., Krishnamoorthy, R., Yolken, R., Dickerson, F., Tamouza, R., Leboyer, M.
Journal of Affective Disorders 2015; 179: 161-166
Click for abstract
Background: Cognitive deficits are present in a large majority of Bipolar Disorder (BD) patients and known to be a marker of bad prognosis. Because, these deficits encompass several domains and no specific medical treatment seems to be effective, it is important to better understand the mechanisms underlying cognitive deterioration. As Toxoplasma gondii is known to induce the synthesis of pro-inflammatory cytokines such as IL-6, we will explore here the possible role of T. gondii in the cognitive decline observed in BD. Methods: 42 euthymic BD patients and 36 controls were assessed for episodic verbal memory using the CVLT and for working memory and verbal ability using the WAIS Ill. Patients and controls were also screened for seropositivity to I gondii and evaluated for the levels of IL-fl transcripts. Results: The seropositivity for I gondii was significantly higher in BD patients as compared to controls (p-0.005). The cognitive deterioration index (Dl) was higher in BD patients (p=5.10 ') and correlated to high IL-6 mRNA expression only among those infected by T gondii (rho-0.43, p-0.01). Among deteriorated patients (defined by scores above 0.10 according to Weschler's definition), the IL-6 mRNA expression was twice greater (p=0.01). Limitations: Our results are to be interpreted with caution because of our small sample size and the cross-sectional design. Conclusions: A long-term exposure to inflammation, measured here with IL-6 mRNA expression in T. gonciii infected BD may alter cognitive functioning. IL-6 could thus be a useful predictive marker of cognitive deterioration in BD and may help to design personalized treatment.

Tagged: antibodies, association, bipolar disorder, cognitive deterioration, exposure, il-6, impairment, individuals, Major depression, risk, Schizophrenia, simplex-virus type-1, t. gondii, traffic accidents

Cognitive functionsMental health

The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii

October 10, 2014
Wang, H. L., Xiang, Y. T., Li, Q. Y., Wang, X. P., Liu, Z. C., Hao, S. S., Liu, X., Liu, L. L., Wang, G. H., Wang, D. G., Zhang, P. A., Bao, A. Y., Chiu, H. F. K., Ungvari, G. S., Lai, K. Y. C., Buchanan, R. W.
Journal of Psychiatric Research 2014; 53: 119-124
Click for abstract
The objective was to evaluate the efficacy and safety of add-on artemether in first-episode, untreated people with schizophrenia, who were Toxoplasma gondii seropositive, and explore the change in T gondii antibodies during treatment. In this eight-week, double-blind, randomized, placebo-controlled trial, 100 T. gondii seropositive participants with schizophrenia were randomized to either the artemether or placebo group. Participants in the artemether group received 80 mg artemether once per day during the second week (days 8-14) and the fourth week (days 22-28). Participants in the placebo group received identical looking placebo capsules. Psychopathology, adverse side effects and cognitive function were measured using standardized instruments. The group x time interaction effects for the scores of the Positive and Negative Syndrome Scale (PANSS) subscales and performances on all cognitive components were not significant, only the main effect of group was significant. Compared to the placebo group, artemether group participants showed significantly greater reduction in the PANSS negative symptom scale (F-(1,F-46) = 4.7, p = 0.03) and the Clinical Global Impressions Scale (F-(1,F-96) = 6.2, p = 0.01) scores, but there were no significant differences in the PANSS positive symptom and general psychopathology scales (p > 0.05). There were also no significant differences between the two groups in performance on any of the Brief Assessment of Cognition in Schizophrenia (BACS) cognitive domains. The artemether risperidone combination is safe and well tolerated, but artemether as an adjunct to risperidone does not appear to alleviate cognitive deficits of schizophrenia. Trial Registration Chinese Clinical Trial Register (ChiCTR) TRC-13003145 (C) 2014 Elsevier Ltd. All rights reserved.

Tagged: acetylcholine-receptors, antibodies, artemether, artemisinin, cognition, derivatives, exposure, growth, inhibition, metaanalysis, progressive brain changes, psychopathology, rodents, Schizophrenia, Toxoplasma gondii

Mental health

Inflammatory molecular signature associated with infectious agents in psychosis

October 9, 2014
Hayes, L. N., Severance, E. G., Leek, J. T., Gressitt, K. L., Rohleder, C., Coughlin, J. M., Leweke, F. M., Yolken, R. H., Sawa, A.
Schizophrenia Bulletin 2014; 40: 963-972
Click for abstract
Schizophrenia (SZ) is a devastating mental condition with onset in young adulthood. The identification of molecular biomarkers that reflect illness pathology is crucial. Recent evidence suggested immune and inflammatory cascades in conjunction with infection may play a role in the pathology. To address this question, we investigated molecular changes in cerebrospinal fluid (CSF) from antipsychoticnaive patients with SZ and at risk mental status for psychosis (ARMS), in comparison with healthy controls (HCs). We measured 90 analytes using a broad multiplex platform focusing on immune and inflammatory cascades then selected 35 with our quality reporting criteria for further analysis. We also examined Toxoplasma gondii (TG) and herpes simplex virus 1 antibody levels in CSF. We report that expression of 15 molecules was significantly altered in the patient groups (SZ and ARMS) compared with HCs. The majority of these molecular changes (alpha-2-macroglobulin [alpha 2M], fibrinogen, interleukin-6 receptor [IL-6R], stem cell factor [SCF], transforming growth factor alpha [TGF alpha], tumor necrosis factor receptor 2 [TNFR2], IL-8, monocyte chemotactic protein 2 [MCP-2/CCL8], testosterone [for males], angiotensin converting enzyme [ACE], and epidermal growth factor receptor) were consistent between SZ and ARMS patients, suggesting these may represent trait changes associated with psychotic conditions in general. Interestingly, many of these analytes (alpha 2M, fibrinogen, IL-6R, SCF, TGF alpha, TNFR2, IL-8, MCP-2/CCL8, and testosterone [for males]) were exacerbated in subjects with ARMS compared with subjects with SZ. Although further studies are needed, we optimistically propose that these molecules may be good candidates for predictive markers for psychosis from an early stage. Lastly, reduction of IL-6R, TGF alpha, and ACE was correlated with positivity of TG antibody in the CSF, suggesting possible involvement of TG infection in the pathology.

Tagged: antibodies, at risk mental status, biomarker, cerebrospinal fluid, exposure, immune activation, inflammation, metaanalysis, pathways, prenatal infection, recent-onset schizophrenia, risk factors, Schizophrenia, simplex-virus 1, Toxoplasma gondii

Mental health

Neonatal antibodies to infectious agents and risk of bipolar disorder: a population-based case-control study

October 16, 2011
Mortensen, P. B., Pedersen, C. B., McGrath, J. J., Hougaard, D. M., Norgaard-Petersen, B., Mors, O., Borglum, A. D., Yolken, R. H.
Bipolar Disorders 2011; 13: 624-629
Tagged: association, bipolar disorder, cohort, cytomegalovirus, dried blood spots, exposure, herpes simplex virus type 1, herpes simplex virus type 2, herpes-simplex-virus, influenza, mood disorders, obstetric complications, psychosis, Schizophrenia, suicide attempts, Toxoplasma gondii

Mental health

A possible relationship between Toxoplasma gondii and schizophrenia: A seroprevalence study

October 26, 2009
Dogruman-Al, F., Aslan, S., Yalcin, S., Kustimur, S., Turk, S.
International Journal of Psychiatry in Clinical Practice 2009; 13: 82-87.
Click for abstract
Objective. Schizophrenia is a pervasive neuropsychiatric disease of uncertain etiology. We aimed to investigate a possible association between Toxoplasma gondii infection and schizophrenia in this study. Method. We selected individuals with schizophrenia (n=88) and tested them with commercially available enzyme-linked immunosorbent assay (ELISA) for anti-Toxoplasma IgG and IgM antibodies and compared these seropositivity rate to those of controls without psychiatric disease (n=88). Results. The rate of IgG antibody in the schizophrenia patients (47.7%) was higher than the control groups (20.4%) (P0.001). We did not find any anti-Toxoplasma IgM seropositivity in both schizophrenia patients and control group. In schizophrenic patients with and without anti-Toxoplasma IgG groups statistical analysis did not reveal any correlation between demographic variables and Toxoplasma infection. Conclusion. Our findings supported previous studies indicate that T.gondii may play a role in etiopathogenesis in some cases of schizophrenia.

Tagged: 1st-episode schizophrenia, anti-toxoplasma igg, anti-toxoplasma igm, antibodies, association, behavior, bipolar disorder, brain, exposure, individuals, infection, necrosis-factor-alpha, Schizophrenia, Toxoplasma gondii

Mental health

Selected infectious agents and risk of schizophrenia among US military personnel

October 26, 2008
Nielbuhr, D.W., Millikan, A. M., Cowan, D. N., Yolken, R., Li, Y. Z., Weber, N. S.
American Journal of Psychiatry 2008; 165: 99-106
Click for abstract
Objective: A number of studies have reported associations between Toxoplasma gondii (T gondii) infection and the risk of schizophrenia. Most existing studies have used small populations and postdiagnosis specimens. As part of a larger research program, the authors conducted a hypothesis-generating case control study of T. gondii antibodies among individuals discharged from the U.S. military with a diagnosis of schizophrenia and serum specimens available from both before and after diagnosis. Method: The patients (N=180) were military members who had been hospitalized and discharged from military service with a diagnosis of schizophrenia. Healthy comparison subjects (3:1 matched on several factors) were members of the military who were not discharged. The U.S. military routinely collects and stores serum specimens of military service members. The authors used microplate-enzyme immunoassay to measure immunoglobulin G (IgG) antibody levels to T gondii, six herpes viruses, and influenza A and B viruses and immunoglobulin M (IgM) antibody levels to T. gondii in pre- and postdiagnosis serum specimens. Results: A significant positive association between the T gondii IgG antibody and schizophrenia was found; the overall hazard ratio was 1.24. The association between IgG and schizophrenia varied by the time between the serum specimen collection and onset of illness. Conclusion: The authors found significant associations between increased levels of scaled T gondii IgG antibodies and schizophrenia for antibodies measured both prior to and after diagnosis.

Tagged: antibodies, association, bipolar disorder, brain, exposure, host, individuals, mice, rats, toxoplasma gondii infection

Mental health

The schizophrenia and Toxoplasma gondii connection: Infectious, immune or both?

October 26, 2008
Tamer, G. S., Dundar, D., Yalug, I., Caliskan, S., Yazar, S., Aker, A.
Advances in Therapy 2008; 25: 703-709
Click for abstract
Introduction: Recent research has suggested a possible link between toxoplasmic agents and schizophrenia. We aimed to assess this by measuring Toxoplasma gondii-associated antibodies in schizophrenia patients and controls. Methods: We used a commercially available enzyme-linked immunosorbent assay (ELISA) kit to measure the level of immunoglobulin G (IgG) and IgM antibodies in serum samples from schizophrenia patients (n= 40) and from a group of non-schizophrenic control subjects (n= 37). Results: Among schizophrenic patients, 16 (40%) showed IgG seropositivity and two (5%) showed IgM seropositivity. Among the control group, five (13.5%) were found have IgG seropositivity and one (2.7%) showed IgM seropositivity. In our study we found that IgG T gondii antibodies were significantly higher in schizophrenia patients compared with controls. Conclusion: This study supports the theory that toxoplasmic agents may have a role in the aetiology of schizophrenia.

Tagged: agents, antibodies, enzyme immunoassay, exposure, individuals, personality, psychosis, risk, Schizophrenia, Toxoplasma gondii

Mental health

Prenatal infection as a risk factor for schizophrenia

October 30, 2006
Brown AS.
Schizophrenia Bulletin 2006; 32: 200-202
Click for abstract
Accumulating evidence suggests that prenatal exposure to infection contributes to the etiology of schizophrenia. This line of investigation has been advanced by birth cohort studies that utilize prospectively acquired data from serologic assays for infectious and immune biomarkers. These investigations have provided further support for this hypothesis and permitted the investigation of new infectious pathogens in relation to schizophrenia risk. Prenatal infections that have been associated with schizophrenia include rubella, influenza, and toxoplasmosis. Maternal cytokines, including interleukin-8, are also significantly increased in pregnancies giving rise to schizophrenia cases. Although replication of these findings is required, this body of work may ultimately have important implications for the prevention of schizophrenia, the elaboration of pathogenic mechanisms in this disorder, and investigations of gene-environment interactions.

Tagged: adult schizophrenia, Epidemiology, exposure, infection, influenza, prenatal, psychosis, Schizophrenia, virus

Mental health

Topics

  • Behavior 105
  • Cognitive functions 64
  • Mental health 439
  • Morphology 6
  • Motor functions 10
  • Personality 36
  • Physical health 134
  • Reproduction 36
  • Reviews 40
  • Sensory functions 3
  • Uncategorized 2

Archives

Recent articles

  • Mortality Patterns of Toxoplasmosis and Its Comorbidities in Tanzania: A 10-Year Retrospective Hospital-Based Survey February 6, 2020
  • The role of latent toxoplasmosis in the aetiopathogenesis of schizophrenia–the risk factor or an indication of a contact with cat? February 6, 2020
  • The Association between Toxoplasma gondii Infection and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis February 6, 2020

Recent Comments

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Copyright © 2023 Toxoplasma gondii & Human Phenotype.

    ToxoBehavior WordPress Theme by Jelena Braum